Stocks in Position to Beat the Failing Market

HENDERSON, NV / ACCESSWIRE / October 18, 2018 / There has been some bad news in the market recently causing some securities to sell off. This has made for some desirable buying opportunities for savvy investors. There are also a few cannabis stocks bucking the trend due to the major legalization event in Canada Wednesday.

So with that said we're highlighting a few companies that can help you beat this market. One company we think has been oversold and looks prime for a bounce is CleanSpark, Inc. (CLSK). If you look at their recent filings you'll the company just inked an $18 million-dollar deal. Also CLSK has the best in class micro-grid technology for the cannabis industry.

The deal calls for CLSK to build one of its patented microgrid systems on Macerich's Thousand Oaks facility in California. Investors searching for oversold opportunities will find this stock and the thing could go hyperbolic. Start your research on CLSK now.

This opportunity won't last much longer so get to it.

Stocks in position to beat this market include: CleanSpark, Inc. (CLSK), Aphria, Inc. (APHQF), GW Pharmaceuticals plc (GWPH), India Globalization Capital, Inc. (IGC), and Cronos Group, Inc. (CRON)

CleanSpark, Inc. (CLSK)

Market Cap: $102.1M Share Price: $2.90

CleanSpark, Inc. (CLSK), is a unique company that offers microgrid solutions for a variety of clients. Matthew Schultz, CEO of CleanSpark, Inc talked with Stock Day's Marcus Heatherly about what they have to offer in energy and software solutions. To listen to the full interview with Matthew Schultz, click the link to the podcast here: https://upticknewswire.com/featured-interview-ceo-s-matthew-schultz-of-cleanspark-inc-otcqb-clsk/

Aurora Cannabis, Inc. (ACBFF)

Market Cap: $10.03B Share Price: $10.44

The company released fiscal fourth-quarter earnings and confirmed its intention to list stock on a "senior" U.S. exchange such as the Nasdaq or the New York Stock Exchange.

Further to this on Friday, October 5, the company filed a Form-40 with the intent of registering its securities on the New York Stock Exchange. Aurora could join the ranks of a growing number of cannabis companies choosing to list on major exchanges in the US. Late last month, Canaccord Genuity raised its price target for Aurora Cannabis to 13 Canadian dollars from 11 Canadian dollars.

Aurora Chief Executive Terry Booth said, "This listing provides access to a broader investor audience who gain the opportunity to participate in our continued success."

Aphria, Inc. (APHQF)

Market Cap: $3.72B Share Price: $14.91

Aphria Inc. (APHQF) announced closing the acquisition of LATAM Holdings Inc. from Scythian Biosciences (SCCYF). The Transaction was funded by the assumption of US$1 million of existing LATAM Holdings debt with the remaining consideration funded by the issuance of 15,678,310 common shares of Aphria. The closing was pursuant to the terms of the definitive share purchase agreement previously announced by the Company on July 17, 2018.

India Globalization Capital, Inc. (NYSE American: IGC)

Market Cap: $148.31M Share Price: $4.46

IGC announced that it has executed a distribution and partnership agreement for several products including a sugar free, energy drink called 'Nitro G'. IGC plans to create a branded, hemp/CBD-infused version of the formulation that addresses market demand for energy drinks with the inclusion of healthy properties derived from hemp including CBD.

GW Pharmaceuticals plc (GWPH)

Market Cap: $4.55B Share Price: $142.05

GW Pharmaceuticals plc, a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, just announced the pricing of an underwritten public offering by the Company. GW will issue 1,900,000 American Depositary Shares, representing 22,800,000 ordinary shares of GW, at a price to the public of $158.00 per ADS on the Nasdaq Global Market, raising gross proceeds of approximately $300 million (before deducting underwriting discounts, commissions and offering expenses). GW granted the underwriters a 30-day option to purchase up to an additional 285,000 ADSs at the public offering price less underwriting discounts and commissions. Closing of the offering is expected to occur on October 5^th , 2018.

Cronos Group, Inc. (CRON)

Market Cap: $2.04B Share Price: $11.56

Earlier this month Cronos announced a partnership with Ginkgo Bioworks. The landmark partnership is to produce cultured cannabinoids. Ginkgo Bioworks, using its platform technology for organism design and development, will complement Cronos Group's technologies for producing a full spectrum of cannabinoids. Cronos Group has agreed to issue a specific number of common shares in tranches subject to Ginkgo's achievement of certain production milestones.

Important Disclaimer, Please Read:

The securities, investments, and industries referenced and impacted in the attached content, are risky investments, that can result in significant or entire loss. This article is not advice in making any speculative investment decision.

The attached content may include predictions, estimates or other information that might be considered forward-looking. While such forward-looking statements represent best judgment on what the future holds, at the time of first publishing, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on any forward-looking statements, that may be found in the attached content, as they only reflect as of the date of first publishing. Please keep in mind that authors, producers, disseminators are not obligated to revise or publicly release the results of any revision to any forward-looking statement, that may be found in the attached content, in light of new information or future events.

Regal Consulting LLC is hired by certain companies to increase awareness and disseminate material public information regarding the paying company. CLSK

has paid, and continues to pay Regal to disseminate truthful and potentially material information regarding CLSK.

Regal Consulting LLC is not registered with FINRA or any other financial or securities regulatory authority, and does not provide investment advice. The attached content is not investment advice. Regal Consulting LLC is not a broker dealer.

Before making investment decisions, everyone, including viewers of this content, should seek advice and perform deep and thorough research.

Regal Consulting, LLC. may buy or sell additional shares of any company named, referenced, or impacted by information in the attached content, on the open market at any time, including before, during or after the publishing of the content. The amount of stock Regal may own in CLSK can be found updated here: http://www.regalconsultingllc.com/disclaimer/.

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. ACR Communication, LLC, which owns Microcapspeculators.com, is not registered with Finra or any other financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. ACR Communication, LLC [and/or] Microcapspeculators.com does not have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. ACR Communication LLC, which owns Microcapspeculators.com, is compensated for its services in the form of cash-based compensation or in equity in the companies it writes about, or a combination of the two. ACR Communication, LLC has been compensated one thousand dollars cash for this article and seven thousand dollars total by Regal Consulting. LLC, for news commentary articles for CLSK. CLSK and Regal Consulting, LLC were given an opportunity to edit information included in this article. This article is based solely on public information and the opinions of ACR Communication, LLC, which believes the news commentary to include accurate and complete information. We may buy or sell additional shares of CLSK in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

For Full Legal Disclaimer Click Here.

Regal Consulting, LLC,For Full Legal Disclaimer Click Here.

Contact Information:

Company Name: Microcap Speculators
Contact Person: Media Manager
Email: info@microcapspecualtors.com
Phone: 1-702-720-6310
Country: United States
Website: http://microcapspeculators.com/

SOURCE: ACR Communication, LLC